Form EFFECT Biodexa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2025 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- At UN General Assembly, Global Autism Advocacy Coalition launches new initiatives to accelerate autism action worldwide
- Global Breakthrough Artist Eylsia Nicolas Redefines Modern Music With the Invention of EOP - Eylsia's Orchestral Pop - Surging to #1 Today on the Global Groover Singer‑Songwriter Charts and Generati
- Stellar Price Prediction: XLM Holds Near $0.22 as Remittix Confirms Its November 24 Token Debut
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
